160 related articles for article (PubMed ID: 32827761)
21. Comparison Between the 2021 USPSTF Lung Cancer Screening Criteria and Other Lung Cancer Screening Criteria for Racial Disparity in Eligibility.
Pu CY; Lusk CM; Neslund-Dudas C; Gadgeel S; Soubani AO; Schwartz AG
JAMA Oncol; 2022 Mar; 8(3):374-382. PubMed ID: 35024781
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of low-dose computed tomography compliance and related factors among high-risk population of lung cancer in three provinces participating in the cancer screening program in urban China].
Wen Y; Yu LZ; Du LB; Wei DH; Liu YY; Yang ZY; Zheng YD; Wu Z; Yu XY; Zhao L; Yu YW; Chen HD; Ren JS; Qin C; Xu YJ; Cao W; Wang F; Li J; Tan FW; Dai M; Chen WQ; Li N; He J
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 May; 55(5):633-639. PubMed ID: 34034404
[No Abstract] [Full Text] [Related]
23. Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers.
Kang HR; Cho JY; Lee SH; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Lee CT
J Thorac Oncol; 2019 Mar; 14(3):436-444. PubMed ID: 30445189
[TBL] [Abstract][Full Text] [Related]
24. [China National Lung Cancer Screening Guideline with Low-dose Computed
Tomography (2018 version)].
Zhou Q; Fan Y; Wang Y; Qiao Y; Wang G; Huang Y; Wang X; Wu N; Zhang G; Zheng X; Bu H; Li Y; Wei S; Chen L; Hu C; Shi Y; Sun Y
Zhongguo Fei Ai Za Zhi; 2018 Feb; 21(2):67-75. PubMed ID: 29526173
[TBL] [Abstract][Full Text] [Related]
25. Perceptions and Utilization of Lung Cancer Screening Among Primary Care Physicians.
Raz DJ; Wu GX; Consunji M; Nelson R; Sun C; Erhunmwunsee L; Ferrell B; Sun V; Kim JY
J Thorac Oncol; 2016 Nov; 11(11):1856-1862. PubMed ID: 27346412
[TBL] [Abstract][Full Text] [Related]
26. Current lung cancer screening guidelines may miss high-risk population: a real-world study.
Ji G; Bao T; Li Z; Tang H; Liu D; Yang P; Li W; Huang Y
BMC Cancer; 2021 Jan; 21(1):50. PubMed ID: 33430831
[TBL] [Abstract][Full Text] [Related]
27. Knowledge of, attitudes toward, and use of low-dose computed tomography for lung cancer screening among family physicians.
Ersek JL; Eberth JM; McDonnell KK; Strayer SM; Sercy E; Cartmell KB; Friedman DB
Cancer; 2016 Aug; 122(15):2324-31. PubMed ID: 27294476
[TBL] [Abstract][Full Text] [Related]
28. Evaluating the impact of varied compliance to lung cancer screening recommendations using a microsimulation model.
Han SS; Erdogan SA; Toumazis I; Leung A; Plevritis SK
Cancer Causes Control; 2017 Sep; 28(9):947-958. PubMed ID: 28702814
[TBL] [Abstract][Full Text] [Related]
29. A National Survey of Pulmonologists' Views on Low-Dose Computed Tomography Screening for Lung Cancer.
Iaccarino JM; Clark J; Bolton R; Kinsinger L; Kelley M; Slatore CG; Au DH; Wiener RS
Ann Am Thorac Soc; 2015 Nov; 12(11):1667-75. PubMed ID: 26368003
[TBL] [Abstract][Full Text] [Related]
30. Lung Cancer Screening: Computed Tomography Radiation and Protocols.
Murugan VA; Kalra MK; Rehani M; Digumarthy SR
J Thorac Imaging; 2015 Sep; 30(5):283-9. PubMed ID: 25856411
[TBL] [Abstract][Full Text] [Related]
31. Smoking behaviors among patients receiving computed tomography for lung cancer screening. Systematic review in support of the U.S. preventive services task force.
Slatore CG; Baumann C; Pappas M; Humphrey LL
Ann Am Thorac Soc; 2014 May; 11(4):619-27. PubMed ID: 24701999
[TBL] [Abstract][Full Text] [Related]
32. [Risk factors for lung cancer based on low-dose computed tomography screening].
Jin YJ; Tang W; Huang Y; Wang JW; Hou DH; Qi LL; Zhao SJ; Wu N
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):222-227. PubMed ID: 32252201
[No Abstract] [Full Text] [Related]
33. Evaluating efficacy of current lung cancer screening guidelines.
Nemesure B; Plank A; Reagan L; Albano D; Reiter M; Bilfinger TV
J Med Screen; 2017 Dec; 24(4):208-213. PubMed ID: 28201949
[TBL] [Abstract][Full Text] [Related]
34. Race & sex disparities related to low-dose computed tomography lung cancer screening eligibility criteria: A lung cancer cases review.
Williams RM; Kareff SA; Sackstein P; Roy T; Luta G; Kim C; Taylor KL; Tammemägi MC
Lung Cancer; 2022 Jul; 169():55-60. PubMed ID: 35644087
[TBL] [Abstract][Full Text] [Related]
35. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
[TBL] [Abstract][Full Text] [Related]
36. Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial.
Balekian AA; Tanner NT; Fisher JM; Silvestri GA; Gould MK
Ann Am Thorac Soc; 2016 Sep; 13(9):1568-74. PubMed ID: 27387658
[TBL] [Abstract][Full Text] [Related]
37. CT Lung Screening in Patients with Laryngeal Cancer.
Piersiala K; Akst LM; Hillel AT; Best SR
Sci Rep; 2020 Mar; 10(1):4676. PubMed ID: 32170175
[TBL] [Abstract][Full Text] [Related]
38. Community-based lung cancer screening with low-dose CT in China: Results of the baseline screening.
Yang W; Qian F; Teng J; Wang H; Manegold C; Pilz LR; Voigt W; Zhang Y; Ye J; Chen Q; Han B;
Lung Cancer; 2018 Mar; 117():20-26. PubMed ID: 29496251
[TBL] [Abstract][Full Text] [Related]
39. Impact of Joint Lung Cancer Screening and Cessation Interventions Under the New Recommendations of the U.S. Preventive Services Task Force.
Meza R; Cao P; Jeon J; Taylor KL; Mandelblatt JS; Feuer EJ; Lowy DR
J Thorac Oncol; 2022 Jan; 17(1):160-166. PubMed ID: 34648947
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
